I agree that this site is using cookies. You can find further informations here.
X
Tricta, Fernando
59  results:
Search for persons X
?
1

Real‐world evidence: Long‐term safety of deferiprone in a l..:

Kwiatkowski, Janet L. ; Thompson, Alexis A. ; Tricta, Fernando...
American Journal of Hematology.  99 (2024)  6 - p. 1031-1039 , 2024
Link: https://doi.org/10.1002/..
 
?
2

Rates of severe neutropenia and infection risk in patients ..:

Badawy, Sherif M. ; Palmblad, Jan ; Tricta, Fernando...
Blood Advances.  , 2024
Link: https://doi.org/10.1182/..
 
?
3

Cardiac iron overload evaluation in thalassaemic patients u..:

Chapchap, Eduardo Cerello ; Silva, Murilo Marques Almeida ; de Assis, Reijane Alves...
Hematology, Transfusion and Cell Therapy.  45 (2023)  1 - p. 7-15 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Deferiprone for transfusional iron overload in sickle cell ..:

Elalfy, Mohsen S. ; Hamdy, Mona ; El-Beshlawy, Amal...
Blood Advances.  7 (2023)  4 - p. 611-619 , 2023
Link: https://doi.org/10.1182/..
 
?
5

Extramedullary haematopoiesis in patients with thalassemia:..:

Chapchap, Eduardo Cerello ; Silva, Murilo Marques Almeida ; Baroni, Ronaldo Hueb...
Hematology, Transfusion and Cell Therapy.  , 2023
Link: https://doi.org/10.1016/..
 
?
6

P1442: PRACTICE-BASED EVIDENCE: LONG-TERM SAFETY COHORT OF ..:

Badawy, Sherif ; Thompson, Alexis ; Tricta, Fernando...
HemaSphere.  7 (2023)  S3 - p. e2943794 , 2023
Link: https://doi.org/10.1097/..
 
?
7

Deferiprone versus deferoxamine for transfusional iron over..:

Hamdy, Mona ; El‐Beshlawy, Amal ; Veríssimo, Mônica P. A....
Pediatric Blood & Cancer.  71 (2023)  1 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
8

Efficacy and safety of early‐start deferiprone in infants a..:

Elalfy, Mohsen S. ; Hamdy, Mona ; Adly, Amira...
American Journal of Hematology.  98 (2023)  9 - p. 1415-1424 , 2023
Link: https://doi.org/10.1002/..
 
?
9

Deferiprone vs deferoxamine for transfusional iron overload..:

Kwiatkowski, Janet L. ; Hamdy, Mona ; El-Beshlawy, Amal...
Blood Advances.  6 (2022)  4 - p. 1243-1254 , 2022
Link: https://doi.org/10.1182/..
 
?
10

The pharmacokinetic and safety profile of single-dose defer..:

Soulières, Denis ; Mercier-Ross, Jules ; Fradette, Caroline...
Annals of Hematology.  101 (2022)  3 - p. 533-539 , 2022
Link: https://doi.org/10.1007/..
 
?
11

Commentary concerning the publication by Zheng X et al.: Me..:

Tricta, Fernando
Xenobiotica.  52 (2021)  3 - p. 332-333 , 2021
Link: https://doi.org/10.1080/..
 
?
12

Rational Design of Novel Therapies for Pantothenate Kinase–..:

Thakur, Nivedita ; Klopstock, Thomas ; Jackowski, Suzanne...
Movement Disorders.  36 (2021)  9 - p. 2005-2016 , 2021
Link: https://doi.org/10.1002/..
 
?
13

The safety and acceptability of twice‐daily deferiprone for..:

Badawy, Sherif M. ; Kattamis, Antonis ; Ezzat, Hatoon...
British Journal of Haematology.  197 (2021)  1 - p. , 2021
Link: https://doi.org/10.1111/..
 
?
14

An insight into Indonesian current thalassaemia care and ch..:

Wahidiyat, Pustika Amalia ; Sari, Teny Tjitra ; Rahmartani, Ludi Dhyani...
ISBT Science Series.  15 (2020)  3 - p. 334-341 , 2020
Link: https://doi.org/10.1111/..
 
?
15

Brain iron chelation by deferiprone in a phase 2 randomised..:

Martin-Bastida, Antonio ; Ward, Roberta J. ; Newbould, Rexford...
Scientific Reports.  7 (2017)  1 - p. , 2017
Link: https://doi.org/10.1038/..
 
1-15